Selective and persistent activation of extracellular signal-regulated protein kinase by nitric oxide in glial cells induces neuronal degeneration in glutathione-depleted midbrain cultures

Molecular and Cellular Neuroscience

Volumn 24, Issue 4, 2003, Pages 1012-1026

  Canals, Santiago ^a   Casarejos, Maria José ^a   De Bernardo, Sonsoles ^a   Solano, Rosa Maria ^a   Mena, Maria Angeles ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 AMINOADIPIC ACID; ASCORBIC ACID; BUTHIONINE SULFOXIMINE; FLUOROACETIC ACID; GLUTATHIONE; GLUTATHIONE ETHYL ESTER; KT 5823; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NITRIC OXIDE; NITRIC OXIDE DONOR;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; DOSE RESPONSE; EMBRYO; ENZYME ACTIVATION; GLIA CELL; IMMUNOCYTOCHEMISTRY; KINETICS; MESENCEPHALON; NERVE CELL DEGENERATION; NEUROTOXICITY; NONHUMAN; OLIGODENDROGLIA; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; STEM CELL;

EID: 0347124698     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2003.08.004     Document Type: Article

References (70)

1. Alvarez-Maubecin V., Garcia-Hernández F., Williams J.T., Van Bockstaele E.J. Functional coupling between neurons and glia. J. Neurosci. 20:2000;4091-4098.
2. Ashwell K. The distribution of microglia and cell death in the fetal rat forebrain. Brain Res. Dev. Brain Res. 58:1991;1-12.
3. Beart P.M., McDonald D. Neurochemical studies of the mesolimbic dopaminergic pathway somatodendritic mechanisms and GABAergic neurons in rat ventral tegmentum . J. Neurochem. 34:1980;1622-1629.
4. Boulton T.G., Nye S.H., Robbins D.J., Ip N.Y., Radziejewska E., Morgenbesser S.D., DePinho R.A., Panayotatos N., Cobb M.H., Yancopoulos G.D. ERKs a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF . Cell. 65:1991;663-675.
5. Callsen D., Pfeilschifter J., Brune B. Rapid and delayed p42/p44 mitogen-activated protein kinase activation by nitric oxide the role of cyclic GMP and tyrosine phosphatase inhibition . J. Immunol. 161:1998;4852-4858.
6. Canals S., Casarejos M.J., Rodriguez-Martin E., de Bernardo S., Mena M.A. Neurotrophic and neurotoxic effects of nitric oxide on fetal midbrain cultures. J. Neurochem. 76:2001;56-68.
7. Canals S., Casarejos M.J., de Bernardo S., Rodriguez-Martin E., Mena M.A. Glutathione depletion switches nitric oxide neurotrophic effects to cell death in midbrain cultures implications for Parkinson's disease . J. Neurochem. 79:2001;1183-1195.
8. Canals S., Casarejos M.J., de Bernardo S., Rodriguez-Martin E., Mena M.A. Nitric oxide triggers the toxicity due to glutathione depletion in midbrain cultures through 12-lipoxygenase. J. Biol. Chem. 278:2003;21542-21549.
9. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature. 410:2001;37-40.
10. Chiarugi P., Fiaschi T., Taddei M.L., Talini D., Giannoni E., Raugei G., Ramponi G. Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. J. Biol. Chem. 276:2001;33478-33487.
11. Cook S.J., Aziz N., McMahon M. The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol. Cell. Biol. 19:1999;330-341.
12. Davis R.J. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268:1993;14553-14556.
13. Decker T., Lohmann-Matthes M.L. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Methods. 115:1988;61-69.
14. Ghatan S., Larner S., Kinoshita Y., Hetman M., Patel L., Xia Z., Youle R.J., Morrison R.S. p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J. Cell Biol. 150:2000;335-347.
15. Griffith O.W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106:1980;207-212.
16. Hazzalin C.A., Mahadevan L.C. MAPK-regulated transcription a continuously variable gene switch . Nat. Rev. Mol. Cell. Biol. 3:2002;30-40.
17. Hilwig I., Gropp A. pH dependent fluorescence of DNA and RNA in cytologic staining with "33342 Hoechst" Exp. Cell Res. 91:1975;457-460.
18. Jiménez L.A., Zanella C., Fung H., Janssen Y.M., Vacek P., Charland C., Goldberg J., Mossman B.T. Role of extracellular signal-regulated protein kinases in apoptosis by asbestos and H2O2. Am. J. Physiol. 273:1997;L1029-L1035.
19. Kenigsberg R.L., Mazzoni I.E. Identification of glial cell types involved in mediating epidermal growth factor's effects on septal cholinergic neurons. J. Neurosci. Res. 41:1995;734-744.
20. Keyser D.O., Pellmar T.C. Synaptic transmission in the hippocampus critical role for glial cells . Glia. 10:1994;237-243.
21. Krieglstein K., Unsicker K. Protein from chromaffin granules promotes survival of mesencephalic dopaminergic neurons by an EGF-receptor ligand-mediated mechanism. J. Neurosci. Res. 48:1997;18-30.
22. Kulich S.M., Chu C.T. Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine implications for Parkinson's disease . J. Neurochem. 77:2001;1058-1066.
23. Lander H.M. An essential role for free radicals and derived species in signal transduction. FASEB J. 11:1997;118-124.
24. Lander H.M., Hajjar D.P., Hempstead B.L., Mirza U.A., Chait B.T., Campbell S., Quilliam L.A. A molecular redox switch on p21(ras) structural basis for the nitric oxide-p21(ras) interaction . J. Biol. Chem. 272:1997;4323-4326.
25. Lander H.M., Jacovina A.T., Davis R.J., Tauras J.M. Differential activation of mitogen-activated protein kinases by nitric oxide-related species. J. Biol. Chem. 271:1996;19705-19709.
26. ras. J. Biol. Chem. 270:1995;7017-7020.
27. ras as a common signaling target of reactive free radicals and cellular redox stress. J. Biol. Chem. 270:1995;21195-21198.
28. Largo C., Cuevas P., Somjen G.G., Martin del Rio R., Herreras O. The effect of depressing glial function in rat brain in situ on ion homeostasis, synaptic transmission, and neuron survival. J. Neurosci. 16:1996;1219-1229.
29. Lu B., Ennis D., Lai R., Bogdanovic E., Nikolov R., Salamon L., Fantus C., Le-Tien H., Fantus I.G. Enhanced sensitivity of insulin-resistant adipocytes to vanadate is associated with oxidative stress and decreased reduction of vanadate (+5) to vanadyl (+4). J. Biol. Chem. 276:2001;35589-35598.
30. Mallis R.J., Buss J.E., Thomas J.A. Oxidative modification of H-ras S-thiolation and S-nitrosylation of reactive cysteines . Biochem. J. 355:2001;145-153.
31. Marshall C.J. Specificity of receptor tyrosine kinase signaling transient versus sustained extracellular signal-regulated kinase activation . Cell. 80:1995;179-185.
32. Mena M.A., Pardo B., Paino C.L., de Yébenes J.G. Levodopa toxicity in foetal rat midbrain neurons in culture modulation by ascorbic acid . NeuroReport. 4:1993;438-440.
33. Michel P.P., Hefti F. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J. Neurosci. Res. 26:1990;428-435.
34. Murphy T.H., Miyamoto M., Sastre A., Schnaar R.L., Coyle J.T. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron. 2:1989;1547-1558.
35. Namura S., Moskowitz M.A., Bonventre J.V. MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc. Natl. Acad. Sci. USA. 96:1999;12866-12869.
36. O'Malley E.K., Sieber B.A., Morrison R.S., Black I.B., Dreyfus C.F. Nigral type 1 astrocytes release a soluble factor that increases dopaminergic neuron survival through mechanisms distinct from basic fibroblast growth factor. Brain Res. 647:1994;83-90.
37. Pardo B., Paino C.L., Casarejos M.J., Mena M.A. Neuronal-enriched cultures from embryonic rat ventral mesencephalon for pharmacological studies of dopamine neurons. Brain Res. Protocols. 1:1997;127-132.
38. Parenti A., Morbidelli L., Cui X.L., Douglas J.G., Hood J.D., Granger H.J., Ledda F., Ziche M. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium. J. Biol. Chem. 273:1998;4220-4226.
39. Perry T.L., Godin D.V., Hansen S. Parkinson's disease a disorder due to nigral glutathione deficiency . Neurosci. Lett. 33:1982;305-310.
40. Peters R.A. Lethal synthesis and carbon-fluorine compounds. Alexander P., Bacq Z.M. Biochemical Lesions and Lethal Synthesis. 1963;88-130 Macmillan, New York.
41. Pileblad E., Magnusson T., Fornstedt B. Reduction of brain glutathione by L-buthionine sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striatum. J. Neurochem. 52:1989;978-984.
42. Raff M.C., Fields K.L., Hakomori S., Mirsky R., Pruss R.M., Winter J. Cell-type-specific markers for distinguishing and studying neurons and the major classes of glial cells in culture. Brain Res. 174:1979;283-308.
43. Raff M.C., Miller R.H., Noble M. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on the culture medium. Nature. 303:1983;390-396.
44. Rao R.K., Clayton L.W. Regulation of protein phosphatase 2A by hydrogen peroxide and glutathionylation, Biochem. Biophys. Res. Commun. 293:2002;610-616.
45. Riederer P., Sofie E., Rausch W.-D., Schmidt B., Reynolds G.P., Jellinger K., Youdim M.B.H. Transition metals, ferritin, glutathione and ascorbic acid in parkinsonian brains. J. Neurochem. 52:1989;515-520.
46. Rodriguez-Martin E., Casarejos M.J., Canals S., de Bernardo S., Mena M.A. Thiolic antioxidants protect from nitric oxide-induced toxicity in fetal midbrain cultures. Neuropharmacology. 43:2002;877-888.
47. Runden E., Seglen P.O., Haug F.M., Ottersen O.P., Wieloch T., Shamloo M., Laake J.H. Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures evidence for a MAP kinase-dependent mechanism . J. Neurosci. 18:1998;7296-7305.
48. Satoh T., Nakatsuka D., Watanabe Y., Nagata I., Kikuchi H., Namura S. Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons. Neurosci. Lett. 288:2000;163-166.
49. Seger R., Krebs E.G. The MAPK signaling cascade. FASEB J. 9:1995;726-735.
50. Sian J., Dexter D.T., Lees A.J., Daniel S.E., Agid Y., Javoy-Agid F., Jenner P., Marsden C.D. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36:1994;348-355.
51. Sommer I., Schachner M. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces an immunocytological study in the central nervous system . Dev. Biol. 83:1981;311-327.
52. Srivastava R.K., Sollott S.J., Khan L., Hansford R., Lakatta E.G., Longo D.L. Bcl-2 and Bcl-X(L) block thapsigargin-induced nitric oxide generation, c-Jun NH(2)-terminal kinase activity, and apoptosis. Mol. Cell. Biol. 19:1999;5659-5674.
53. Stamler J.S., Lamas S., Fang F.C. Nitrosylation the prototypic redox-based signaling mechanism . Cell. 106:2002;675-683.
54. Stanciu M., DeFranco D.B. Prolonged nuclear retention of activated extracellular signal-regulated protein kinase promotes cell death generated by oxidative toxicity or proteasome inhibition in a neuronal cell line. J. Biol. Chem. 277:2002;4010-4017.
55. Stanciu M., Wang Y., Kentor R., Burke N., Watkins S., Kress G., Reynolds I., Klann E., Angiolieri M.R., Johnson J.W., DeFranco D.B. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem. 275:2000;12200-12206.
56. Streit W.J., Kreutzberg G.W. Lectin binding by resting and reactive microglia. J. Neuroimmunol. 16:1987;249-260.
57. Taimor G., Rakow A., Piper H.M. Transcription activator protein 1 (AP-1) mediates NO-induced apoptosis of adult cardiomyocytes. FASEB J. 15:2001;2518-2520.
58. Thomas G., Thomas G., Pierre J., Jacquemin C., Pierre M., Saunier B. Mediation by arachidonic acid metabolites of the H2O2-induced stimulation of mitogen-activated protein kinases (extracellular-signal-regulated kinase and c-Jun NH2-terminal kinase). Eur. J. Biochem. 244:1997;587-595.
59. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione application to mammalian blood and other tissue . Anal. Biochem. 27:1969;502-522.
60. Toffa S., Kunikowska G.M., Jenner P., Marsden C.D. Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration. J. Neural Transm. 104:1997;67-75.
61. 12) signaling pathway by cyclic AMP potentiates the neuroprotective effect of the neurotransmitter noradrenaline on dopaminergic neurons. Mol. Pharmacol. 62:2002;1043-1052.
62. Turner N.A., Xia F., Azhar G., Liu L., Wei J.Y. Oxidative stress induces DNA fragmentation and caspase activation via the c-Jun NH2-terminal kinase pathway in H9c2 cardiac muscle cells. J. Mol. Cell. Cardiol. 30:1998;1789-1801.
63. Waniewski R.A., Martin D.L. Preferential utilization of acetate by astrocytes is attributable to transport. J. Neurosci. 18:1998;5233.
64. Weber G.F. Final common pathways in neurodegenerative diseases regulatory role of the glutathione cycle . Neurosci. Biobehav. Rev. 23:1999;1079-1086.
65. Wullner U., Loschmann P.A., Schulz J.B., Schmid A., Dringen R., Eblen F., Turski L., Klockgether T. Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones. NeuroReport. 7:1996;921-923.
66. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
67. 2 phosphorylation and arachidonic acid release in primary murine astrocytes. J. Neurochem. 83:2002;259-270.
68. Yamazaki M., Chiba K., Mohri T., Hatanaka H. Activation of the mitogen-activated protein kinase cascade through nitric oxide synthesis as a mechanism of neuritogenic effect of genipin in PC12h cells. J. Neurochem. 79:2001;45-54.
69. Yujiri T., Sather S., Fanger G.R., Johnson G.L. Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption. Science. 282:1998;1911-1914.
70. Yun H.-Y., Gonzalez-Zulueta M., Dawson V.L., Dawson T.M. Nitric oxide mediates N-methyl-D-aspartate receptor-induced activation of p21ras. Proc. Natl. Acad. Sci. USA. 95:1998;5773-5778.